FiledIssuerIndustrySold
Oct 2025TAO Synergies Inc.Other$11M
Sept 2025TNF Pharmaceuticals, Inc.Pharmaceuticals$7.0M
Sept 2025PharmaCyte Biotech, Inc.Biotechnology$7.0M
Aug 2025AYRO, Inc.Other$7.0M
Jun 2025Synaptogenix, Inc.Biotechnology$5.5M
Jan 2025XWELL, Inc.Other Health Care$4.0M
Sept 2024Synaptogenix, Inc.Biotechnology$3.2M
May 2024MyMD Pharmaceuticals, Inc.Pharmaceuticals$15M
May 2024MyMD Pharmaceuticals, Inc.Pharmaceuticals$27M
Jan 2023Guerrilla RF, Inc.Other Technology$5.0M
Dec 2022Aeluma, Inc.Other Technology$1.6M
Aug 2022Intuitive Lumicell LLCInvesting$1.9M
May 2022Intuitive HZO III, LLCInvesting$1.9M
Jan 2022SmartKem, Inc.Other Technology$2.0M
Dec 2021Intuitive Bitvore, LLCInvesting$1.0M
Nov 2021Guerrilla RF, Inc.Other Technology$7.2M
Nov 2021Intuitive HelloGbye LLCInvesting$460k
Aug 2021Intuitive Lumicell LLCInvesting$4.3M
Jul 2021Aeluma, Inc.Other Technology$8.0M
May 2021Intuitive Virsec LLCInvesting$5.1M
May 2021Ashvattha Therapeutics, Inc.Biotechnology$7.7M
Apr 2021PeerNova, Inc.Agents: GP NurmenkariOther Technology$12M
Apr 2021Intuitive PeerNova LLCInvesting$1.4M
Apr 2021Odyssey Semiconductor Technologies, Inc.Other Technology$5.0M
Mar 2021Amgine Technologies (US), Inc.Other Technology$350k
Feb 2021SmartKem, Inc.Other Technology$25M
Feb 2021Synaptogenix, Inc.Biotechnology$14M
Nov 2020Intuitive Ostendo, LLCInvesting$400k
Oct 2020Augmedix, Inc.Other Health Care$26M
Sept 2020Intuitive Incodema3D LLCInvesting$409k
Jun 2020Angion Biomedica Corp.Biotechnology$6.7M
May 20209 Meters Biopharma, Inc.Agents: GP Numenkari Inc.Pharmaceuticals$23M
Feb 2020Intuitive Ostendo, LLCInvesting$2.6M
Jan 2020Angion Biomedica Corp.Biotechnology$1.0M
Jan 2020Angion Biomedica Corp.Biotechnology$6.1M
Dec 2019Entera Bio Ltd.Agents: GP Nurmenkari, Inc.Biotechnology$14M
Nov 2019PeerNova, Inc.Agents: GP Nurmenkari, Inc.Other Technology$28M
Oct 2019Iota Communications, Inc.Other Technology$1.5M
Aug 2019CALIENT Technologies INCTelecommunications$32M
Jul 2019Incodema3D Holdings, Inc.Manufacturing$715k
From the SEC's Form D data sets: the issuer named this firm as paid to sell the offering. The latest 40 shown.